Qiongfang Wu

Prof. Dr. Qiongfang Wu

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2022 in Journal of Inflammation Research
Verified
Journal Article
Open access
PDF file
JHJialyu Huang
Jialyu Huang
LXLeizhen Xia
Leizhen Xia
JLJiaying Lin
Jiaying Lin
BLBangdong Liu
Bangdong Liu
YZYan Zhao
Yan Zhao
QWQiongfang Wu
Qiongfang Wu
Purpose: To investigate the impact of inactivated SARS-CoV-2 vaccination on in vitro fertilization (IVF) outcomes. Patients and Methods: This retrospective cohort study included 2185 patients undergoing fresh IVF cycles from June 1st to September 13th 2021 in a single university-affiliated hospital. Vaccine administration information was collected and ascertained via immunization records. Patients with two dosages of inactivated SARS-CoV-2 vaccines (Sinopharm or Sinovac) were categorized into the vaccinated group (n = 150), while those unvaccinated were classified as control (n = 2035). Propensity score matching was performed to balance the baseline characteristics (14 covariates) between the two groups at a ratio of 1:4. The main outcome measures were the number of oocytes retrieved, good-quality embryo rate and clinical pregnancy rate. Results: There were 146 women in the vaccinated group and 584 in the control group after matching. The number of oocytes retrieved (9.9 ± 7.1 vs 9.9 ± 6.7; P = 0.893), good-quality embryo rate (33.5 ± 29.8% vs 29.9 ± 28.6%; P = 0.184) and clinical pregnancy rate (59.1% vs 63.6%; P = 0.507) were all similar between the two groups. In addition, no significant differences were observed regarding other cycle characteristics, laboratory parameters and pregnancy outcomes. The results were also comparable when vaccinated patients were subdivided into three categories based on the time interval from complete vaccination to cycle initiation: ≤ 1 month, > 1– 2 months, and > 2 months. Conclusion: Our study provided the first-time evidence that inactivated SARS-CoV-2 vaccination in females did not result in any measurable detrimental effects on IVF treatment. Owing to the present limitations, further prospective studies with larger cohort size and longer follow-up are warranted to validate our conclusion.

11 March 2022 in BMC Pregnancy and Childbirth
Verified
Journal Article
Open access
PDF file
LTLifeng Tian
Lifeng Tian
LXLeizhen Xia
Leizhen Xia
HLHongbo Liu
Hongbo Liu
YKYan Kou
Yan Kou
ZHZhihui Huang
Zhihui Huang
QWQiongfang Wu
Qiongfang Wu
Purpose: To study the relationship between blastomere number and pregnancy outcomes of day 3 embryo transfers. Methods: This retrospective cohort study included 2237 fresh single day 3 embryo transfer cycles from October 2013 to November 2020. Patients were divided into six groups according to the blastomere number on day 3: ≤ 6-cell (n = 100), 7-cell (n = 207), 8-cell (n = 1522), 9-cell (n = 187), 10-cell (n = 91) and ≥ 11-cell (n = 130). Generalized estimating equation analysis based on multivariate logistic regression model was performed to adjust for potential confounders. Results: The live birth rate (LBR) was 19.0%, 27.1%, 38.9%, 32.1%, 44.0% and 53.8% for the ≤ 6-cell, 7-cell, 8-cell, 9-cell, 10-cell and ≥ 11-cell groups, respectively (P < 0.001). Specifically, the ≤ 6-cell group was associated with reduced LBR compared with the 8-cell group (aOR 0.50, 95% CI 0.29–0.86; P = 0.013). Conversely, the odds of live birth were significantly increased in patients transferred with 10-cell embryos (aOR 1.62, 95% CI 1.03–2.53; P = 0.035) and ≥ 11-cell embryos (aOR 2.14, 95% CI 1.47–3.11; P < 0.001) when using the 8-cell embryo group as reference. Similar trends were also observed in the rates of positive hCG test and clinical pregnancy, while no significant differences were detected in miscarriage risk. Conclusion: Increased blastomere number was associated with higher LBR in fresh single day 3 embryo transfer cycles. This finding questions the consensus on the reduced developmental potential of fast-cleaving embryos. Further large prospective studies are warranted for confirmation.

29 November 2021 in Frontiers in Endocrinology
Verified
Journal Article
Open access
JHJialyu Huang
Jialyu Huang
JLJiaying Lin
Jiaying Lin
LXLeizhen Xia
Leizhen Xia
LTLifeng Tian
Lifeng Tian
DXDingfei Xu
Dingfei Xu
QWQiongfang Wu
Qiongfang Wu
Purpose: To evaluate the association of endometrial thickness (EMT) with obstetric and neonatal outcomes in women with polycystic ovary syndrome (PCOS).Methods: A total of 1755 subfertile PCOS women with singleton livebirths after frozen-thawed embryo transfer were included between January 2009 and September 2019. Main obstetric outcomes were hypertensive disorders in pregnancy and abnormal placentation. Main neonatal outcomes were preterm birth (PTB), low birthweight (LBW) and small-for-gestational age (SGA). Crude and adjusted odds ratios (ORs) with 95% confidence intervals (CIs) were estimated by univariate and multivariate logistic regression analyses.Results: Each millimeter decrease in EMT was related to a 9% (adjusted OR 1.09, 95% CI 1.00–1.19; P = 0.053), 14% (adjusted OR 1.14, 95% CI 1.02–1.28; P = 0.002) and 22% (adjusted OR 1.22, 95% CI 1.07–1.38; P = 0.003) higher risk of PTB, LBW and SGA, respectively. Compared to women with EMT >13 mm, women with EMT ≤8 mm also had significantly higher risk of PTB (adjusted OR 3.79, 95% CI 1.53–9.39; P = 0.004), LBW (adjusted OR 4.33, 95% CI 1.39–13.50; P = 0.012) and SGA (adjusted OR 6.38, 95% CI 1.78–22.83; P = 0.004). These associations remained consistent in further subgroup analysis by endometrial preparation regimen and in sensitivity analyses among nulligravida women or women without adverse obstetric outcomes. No significant differences were found in the incidence of several pregnancy complications across EMT categories.Conclusion: Decreased EMT was independently associated with increased risk of PTB, LBW and SGA in women with PCOS.

8 November 2022 in Journal of Medical Virology
Verified
Journal Article
Closed access
JHJialyu Huang
Jialyu Huang
ZFZheng Fang
Zheng Fang
LHLingling Huang
Lingling Huang
LFLu Fan
Lu Fan
YLYiqi Liu
Yiqi Liu
QWQiongfang Wu
Qiongfang Wu

8 September 2022 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
JHJialyu Huang
Jialyu Huang
LXLeizhen Xia
Leizhen Xia
LTLifeng Tian
Lifeng Tian
DXDingfei Xu
Dingfei Xu
ZFZheng Fang
Zheng Fang
QWQiongfang Wu
Qiongfang Wu
Mass vaccination campaigns have been conducted worldwide to control the COVID-19 pandemic. Despite reassuring safety profiles in clinical trials, vaccine hesitancy remains high among individuals of reproductive age, partially because of fertility concerns.1 Recent studies have shown that messenger RNA and viral-vector SARS-CoV-2 vaccinations do not impair sperm parameters among participants.2-5 However, the effects of inactivated SARS-CoV-2 vaccines—the most widely used vaccine type in mainland China—on semen quality have not been assessed. We evaluated changes in semen quality before and after inactivated SARS-CoV-2 vaccination among men in China.

9 December 2022 in International Immunopharmacology
Verified
Journal Article
Closed access
JHJialyu Huang
Jialyu Huang
YLYiqi Liu
Yiqi Liu
HZHan Zeng
Han Zeng
LTLifeng Tian
Lifeng Tian
YHYina Hu
Yina Hu
QWQiongfang Wu
Qiongfang Wu